Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines

可乐

书目名称Immunosuppression under Trial影响因子(影响力)




书目名称Immunosuppression under Trial影响因子(影响力)学科排名




书目名称Immunosuppression under Trial网络公开度




书目名称Immunosuppression under Trial网络公开度学科排名




书目名称Immunosuppression under Trial被引频次




书目名称Immunosuppression under Trial被引频次学科排名




书目名称Immunosuppression under Trial年度引用




书目名称Immunosuppression under Trial年度引用学科排名




书目名称Immunosuppression under Trial读者反馈




书目名称Immunosuppression under Trial读者反馈学科排名

GEON

Retrieval

Minimal standards for reporting clinical trial results in transplantationbenefit of that therapy. Not all therapeutic decisions in medicine are based on the results of clinical trials. For example, insulin is the standard treatment of diabetic ketoacidosis, even though this therapy was never tested in a randomized controlled trial. Similarly, the need to use immunosuppre

微枝末节

傀儡

FILLY

冷漠

Factors influencing long-term allograft survival the steady attrition of transplanted organs due to chronic rejection. The UNOS published half-life for cadaveric renal allografts is approximately 8.5 years, not significantly different from the 7.7 year half-life published for cadaveric renal allografts under azathioprine-prednisone immunosuppress

hair-bulb

progestogen

Cardiovascular complications after renal transplantation than 49.2% by death with a functioning graft, while other causes account for a further 9.4%. Thus, reduction of cardiovascular death will be a very efficient measure to preserve grafts. According to the EDTA Registry [2], the frequency of death from cardiovascular causes increases markedly with age

EXCEL

Strategies to minimize nephrotoxicity associated to calcineurin inhibitorsclosporine and tacrolimus has been reported [1–3]. Mihatsch et al. [4] found that the side effect pattern of these drugs is nearly identical: they were unable to differentiate morphological changes associated with their clinical nephrotoxicity.